ASHLEY DELAUNOIS: Open Payments
NPI 1699397539 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 10 payments from 6 companies in 2025. Trend: 2023 $539 · 2024 $791 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $109 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: ARISTADA, INVEGA SUSTENNA, COBENFY, CAPLYTA, UZEDY, ABILIFY MAINTENA.
Industry payments across IN — which companies pay providers there.
